Inozyme PharmaINZY 
$5.81-0.34%24h
-0.34%24h
Global rank13547
Market cap$358.83M
Change 7d1.57%
YTD Performance37.35%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Inozyme Pharma (INZY)
As of November 2024, Inozyme Pharma has a market cap of $358.83M. This makes Inozyme Pharma the world's 13547th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Inozyme Pharma from 2020 to 2024
-
Value:-
Market cap history of Inozyme Pharma from 2020 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $351.73M | 33.69% |
| 2023 | $263.10M | 305.71% |
| 2022 | $64.85M | -84.60% |
| 2021 | $421.21M | -66.96% |
| 2020 | $1.27B | - |
INZY Market Cap Today is $358.83M -0.34% - 20 Nov 2024
View largest stocks by market cap 
